Chirumamilla Amala P, Wilson Michael F, Wilding Gregory E, Chandrasekhar Rameela, Ashraf Hashmat
University at Buffalo, State University of New York, Buffalo, NY, USA.
Cardiology. 2008;111(1):23-9. doi: 10.1159/000113423. Epub 2008 Feb 1.
Renal insufficiency (RI) is a prognostic marker in patients with cardiovascular disease. In this study, the latest standard of glomerular filtration rate (GFR) calculation, that is the modification of diet in renal disease (MDRD) study equation, is used to measure the difference in the outcome of coronary artery bypass graft (CABG) surgery in various GFR groups. Between 2000 and 2005, 1,055 patients underwent CABG surgery and were categorized into 5 groups according to the National Kidney Foundation guidelines: stage 1 = normal renal function; stage 2 = mild RI; stage 3 = moderate RI; stage 4 = severe RI; stage 5 = end-stage renal failure (excluded). Precautions were taken in RI patients to avoid perioperative hypotension, fluid overload and limited cardioplegia; cardiopulmonary bypass time was kept at a minimum by performing an essential number of grafts only. Thirty-day mortality occurred in 5 of 1,052 patients (0.48%) with no statistical difference in stages 1-4. There was increase in bleed requiring reoperation and total complications from stages 1 to 4, but it was not statistically significant. Preoperative renal dysfunction in CABG surgery patients is an important predictor of outcome. Patients undergoing CABG surgery can have acceptable results without significant increase in complications and mortality provided that risk factors are minimized perioperatively.
肾功能不全(RI)是心血管疾病患者的一个预后指标。在本研究中,采用最新的肾小球滤过率(GFR)计算标准,即肾脏病饮食改良(MDRD)研究方程,来测量不同GFR组冠状动脉旁路移植术(CABG)的手术结果差异。2000年至2005年期间,1055例患者接受了CABG手术,并根据美国国家肾脏基金会指南分为5组:1期 = 肾功能正常;2期 = 轻度RI;3期 = 中度RI;4期 = 重度RI;5期 = 终末期肾衰竭(排除)。对RI患者采取了预防措施,以避免围手术期低血压、液体超负荷和限制心脏停搏液的使用;仅通过进行必要数量的移植手术,将体外循环时间保持在最短。1052例患者中有5例(0.48%)发生30天死亡率,1 - 4期无统计学差异。从1期到4期,需要再次手术的出血和总并发症有所增加,但无统计学意义。CABG手术患者术前肾功能不全是预后的重要预测指标。只要围手术期将危险因素降至最低,接受CABG手术的患者可以获得可接受的结果,而并发症和死亡率不会显著增加。